SCHEMBL20591228

SCHEMBL20591228

CC(=O)c1ccc(Sc2nc3ccccc3s2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.56
▸ HPGD P15428 4/20 0.53
▸ ALDH1A1 P00352 4/20 0.53
▸ POLB P06746 3/20 0.51
▸ APEX1 P27695 1/20 0.51
▸ RECQL P46063 1/20 0.51
▸ RAB9A P51151 2/20 0.51
▸ HSPD1 P10809 2/20 0.51
▸ HSPE1 P61604 2/20 0.51
▸ HSD17B10 Q99714 2/20 0.50
▸ FBP1 P09467 2/20 0.50
▸ LMNA P02545 2/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ ADRA2A P08913 1/20 0.50
▸ ADORA3 P0DMS8 1/20 0.50
▸ DRD2 P14416 1/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ ADRA2B P18089 1/20 0.50
▸ ADRA2C P18825 1/20 0.50
▸ DRD1 P21728 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3332698 0.81 MAPT (0.39) MAPTHPGDALDH1A1POLBAPEX1
SCHEMBL8363011 0.80 FBP1 (0.58) MAPTHPGDALDH1A1POLBAPEX1
SCHEMBL11591375 0.80 ALDH1A1 (0.58) MAPTHPGDALDH1A1POLBAPEX1
SCHEMBL1876191 0.80 HPGD (0.66) MAPTHPGDALDH1A1POLBAPEX1
SCHEMBL2732885 0.78 HSPD1 (0.64) MAPTALDH1A1RAB9AHSPD1HSPE1
SCHEMBL24118880 0.78 SMN1; SMN2 (0.67) MAPTHPGDALDH1A1POLBRAB9A
SCHEMBL8563621 0.77 FBP1 (0.58) MAPTHPGDALDH1A1POLBAPEX1
SCHEMBL11333963 0.77 FBP1 (0.74) MAPTHPGDALDH1A1POLBAPEX1
SCHEMBL31038108 0.77 FBP1 (0.58) MAPTHPGDALDH1A1POLBAPEX1
SCHEMBL31038096 0.77 FBP1 (0.74) MAPTHPGDALDH1A1POLBAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11427536-B2 Photocatalyst-free, light-induced carbon-sulfur cross-coupling methods THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2022-08-30 — — US disclosed
US-20180370911-A1 PHOTOCATALYST-FREE, LIGHT-INDUCED CARBON-SULFUR CROSS-COUPLING METHODS U.S. DEPARTMENT OF ENERGY 2018-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180370911-A1 PHOTOCATALYST-FREE, LIGHT-INDUCED CARBON-SULFUR CROSS-COUPLING METHODS TST, CBS, CRY2 MAPT 3163/4885HPGD 1394/4885ALDH1A1 716/4885
US-11427536-B2 Photocatalyst-free, light-induced carbon-sulfur cross-coupling methods TST, CBS, CRY2 MAPT 3163/4885HPGD 1394/4885ALDH1A1 716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback